HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between leptin receptor gene polymorphisms and early-onset prostate cancer.

AbstractOBJECTIVE:
To report a case-control study examining the relationship between polymorphisms in the leptin receptor (OBR) gene and the development of young-onset prostate cancer, because epidemiological studies report that prostate cancer risk is associated with animal fat intake, and thus we investigated if this association occurs via this genetic mechanism.
PATIENTS, SUBJECTS AND METHODS:
The Lys109Arg (OBR1) and Gln223Arg (OBR2) polymorphisms in the coding region of OBR were studied in blood DNA from 271 patients with prostate cancer aged < 56 years at diagnosis and 277 geographically matched control subjects. Cases were collected through the Cancer Research UK/British Prostate Group Familial Prostate Cancer Study. Blood DNA was genotyped using the polymerase chain reaction and a restriction enzyme digest.
RESULTS:
There was no statistically significant association between the OBR genotype and prostate cancer risk; men homozygous for 109Arg genotype had a slightly increased risk for prostate cancer, with a relative risk (95% confidence interval) of 1.36 (0.65-2.85), and those homozygous for the 223Arg allele had some reduction in prostate cancer risk, at 0.82 (0.58-1.26), but neither was statistically significant.
CONCLUSION:
This case-control study showed no significant association between leptin receptor gene polymorphisms and the risk of young-onset prostate cancer, suggesting that genetic variations in OBR are unlikely to have a major role in the development of early-onset prostate cancer in the UK.
AuthorsZ Kote-Jarai, R Singh, F Durocher, D Easton, S M Edwards, A Ardern-Jones, D P Dearnaley, R Houlston, R Kirby, R Eeles
JournalBJU international (BJU Int) Vol. 92 Issue 1 Pg. 109-12 (Jul 2003) ISSN: 1464-4096 [Print] England
PMID12823393 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • Intracellular Signaling Peptides and Proteins
  • LEPROT protein, human
Topics
  • Adult
  • Age of Onset
  • Carrier Proteins (genetics)
  • Case-Control Studies
  • Genotype
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Male
  • Middle Aged
  • Polymorphism, Genetic (genetics)
  • Prostatic Neoplasms (genetics)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: